InfuSystem Holdings, Inc (INFU) stock
INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 13/302% above fair value
$14.67−0.12 (-0.81%)
Close on Nov 18, 2026Market cap $292.19MP/E 35.8Yield –
InfuSystem operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
InfuSystem's operating income for the twelve months ending Jun 30, 2026 was $13.27M, up 29.1% year over year. For fiscal 2025 it was $11.92M, up 73.0% from the year before. Over ten years it grew 5.1% a year on average. The highest annual figure on record is $11.92M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.92M | +73.0% |
| FY2024 | Dec 31, 2024 | $6.89M | +68.6% |
| FY2023 | Dec 31, 2023 | $4.09M | +147.2% |
| FY2022 | Dec 31, 2022 | $1.65M | -41.3% |
| FY2021 | Dec 31, 2021 | $2.82M | -68.1% |
| FY2020 | Dec 31, 2020 | $8.83M | +150.4% |
| FY2019 | Dec 31, 2019 | $3.53M | +749.4% |
| FY2018 | Dec 31, 2018 | $415.00K | – |
| FY2017 | Dec 31, 2017 | -$3.81M | -491.4% |
| FY2016 | Dec 31, 2016 | $974.00K | -86.6% |
| FY2015 | Dec 31, 2015 | $7.28M | -22.0% |
| FY2014 | Dec 31, 2014 | $9.33M | +58.3% |
| FY2013 | Dec 31, 2013 | $5.90M | +194.8% |
| FY2012 | Dec 31, 2012 | $2.00M | – |
| FY2011 | Dec 31, 2011 | -$66.36M | – |
| FY2010 | Dec 31, 2010 | -$938.00K | -117.6% |
| FY2009 | Dec 31, 2009 | $5.33M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.15M | +9.9% |
| Q1 FY2026 | Mar 31, 2026 | $1.59M | +157.3% |
| Q4 FY2025 | Dec 31, 2025 | $3.71M | +42.0% |
| Q3 FY2025 | Sep 30, 2025 | $3.81M | +16.7% |
| Q2 FY2025 | Jun 30, 2025 | $3.78M | +103.6% |
| Q1 FY2025 | Mar 31, 2025 | $618.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $2.62M | +109.3% |
| Q3 FY2024 | Sep 30, 2024 | $3.27M | +92.4% |
| Q2 FY2024 | Jun 30, 2024 | $1.86M | +48.6% |
| Q1 FY2024 | Mar 31, 2024 | -$845.00K | – |
| Q4 FY2023 | Dec 31, 2023 | $1.25M | +21.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.70M | +80.0% |
| Q2 FY2023 | Jun 30, 2023 | $1.25M | +502.9% |
| Q1 FY2023 | Mar 31, 2023 | -$107.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $1.03M | -35.8% |
| Q3 FY2022 | Sep 30, 2022 | $943.00K | – |
| Q2 FY2022 | Jun 30, 2022 | $207.00K | -70.3% |
| Q1 FY2022 | Mar 31, 2022 | -$525.00K | -160.1% |
| Q4 FY2021 | Dec 31, 2021 | $1.60M | +54.8% |
| Q3 FY2021 | Sep 30, 2021 | -$351.00K | -110.8% |
| Q2 FY2021 | Jun 30, 2021 | $696.00K | -84.6% |
| Q1 FY2021 | Mar 31, 2021 | $873.00K | +2545.5% |
| Q4 FY2020 | Dec 31, 2020 | $1.04M | -21.1% |
| Q3 FY2020 | Sep 30, 2020 | $3.25M | +95.6% |
| Q2 FY2020 | Jun 30, 2020 | $4.51M | +364.1% |
| Q1 FY2020 | Mar 31, 2020 | $33.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $1.31M | +940.5% |
| Q3 FY2019 | Sep 30, 2019 | $1.66M | – |
| Q2 FY2019 | Jun 30, 2019 | $971.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$420.00K | -171.4% |
| Q4 FY2018 | Dec 31, 2018 | $126.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$95.00K | -117.0% |
| Q2 FY2018 | Jun 30, 2018 | -$204.00K | – |
| Q1 FY2018 | Mar 31, 2018 | $588.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.31M | – |
| Q3 FY2017 | Sep 30, 2017 | $560.00K | -2.8% |
| Q2 FY2017 | Jun 30, 2017 | -$1.09M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.97M | – |
| Q4 FY2016 | Dec 31, 2016 | -$454.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $576.00K | – |
See a number that looks wrong?